06006753 is referenced by 145 patents and cites 7 patents.

This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.

Title
Use of GLP-1 or analogs to abolish catabolic changes after surgery
Application Number
8/916991
Publication Number
6006753
Application Date
August 21, 1997
Publication Date
December 28, 1999
Inventor
Suad Efendic
Lidingo
SE
Agent
Barnes & Thornburg
Assignee
Eli Lilly and Company
IN, US
IPC
A61B 19/00
View Original Source